Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Live Attenuated Varicella Vaccine in Healthy Volunteers
NCT02965404Phase 1Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Apr 2016
- Primary completion
- May 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of varicella vaccine live in varicella (VZV) (3 arms), sponsored by Sinovac Biotech Ltd. Primary endpoint: Incidences of adverse events at 30 days. Started Apr 2016; status: completed.
02
Drugs
varicella vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT02965404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965404.